History of Beutner Laboratories
Beutner Laboratories was founded by Ernst and Gloria Beutner in 1992. Development of defined, quantified Immnofluorescent (IF) methods now used for studies of autoimmune skin diseases started with studies of experimental autoimmune thyroiditis at the State University of New York at Buffalo (UB) under the leadership of Ernest Witebsky, M.D. and with guidance from Albert Coons, M.D. at Harvard University.
From 1968 to 1992 Tadeusz Chorzelski, M.D. and his chief, Stefania Jablonska, M.D. of the Warsaw Medical School, Poland joined with Beutner's group at UB in studies that yielded over 125 publications on autoimmunity in skin disease, 5 edited books and 8 summer teaching programs in the 1970's primarily for dermatologists on uses of IF methods in studies of skin immunopathology. Also from 1965 to 1985 Beutner and his associates at UB led an international effort to introduce defined IF into diverse immunologic studies by quantifying fluorescein to protein ratios and labeled antibody protein content of fluorescein conjugated antibodies. This formed the foundation for the present day reproducible defined Immnofluorescence.